TY  - JOUR

T1  - Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

JO  - Pharmacoeconomics

UR  - https://eprints.whiterose.ac.uk/id/eprint/128255

PY  - 2018/07/01

AU  - Stevenson M

AU  - Pandor A

AU  - Hamilton J

AU  - Stevens J

AU  - Rowntree C

AU  - Martyn-St James M

AU  - Rawdin A

AU  - Wong R

ED  - 

DO  - DOI: 10.1007/s40273-018-0624-7

PB  - Springer Verlag

VL  - 36

IS  - 7

SP  - 759

EP  - 768

Y2  - 2025/10/31

ER  -